https://www.selleckchem.com/products/sc75741.html
First observed in 1920s, the Warburg effects have inspired scientists to harness the unique glucose metabolism of cancer cells for targeted therapy for a century. Carbohydrate-drug conjugates are explicitly designed for selective uptake by cancer cells overexpressing glucose transporters. We summarize the progress in developing glycoconjugates for cancer-specific targeting and treatment over the past decade (2010-202 and point to some future directions in this field. The rapid pace of the severe acute respiratory syndrome coronavirus
Like
Comment
Share
